The Aakaar Medical Technologies IPO will open on June 20, 2025, and close on June 24, 2025. It is a Book Built Issue, aiming to raise approximately ₹27 crores through a fresh issue of ₹27 crores and an offer for sale of up to [.] equity shares, each with a face value of ₹10.

The IPO price band is set between ₹68 and ₹72 per share. The allocation is divided as follows: 35% for retail investors, 50% for Qualified Institutional Buyers (QIB), and 15% for High Net-Worth Individuals (HNI). The shares are scheduled to be listed on the NSE on June 27, 2025, with allotment expected on June 25, 2025.

For the financial year 2025, the company reported revenue of ₹61.76 crores, up from ₹46.27 crores in 2024. The profit also rose to ₹6.04 crores in 2025 compared to ₹2.87 crores in the previous year. Based on these financials, the IPO appears to be a strong candidate for long-term investment.

About Aakaar Medical Technologies IPO

Founded in 2013, Aakaar Medical Technologies Ltd. has emerged as a prominent name in the medical industry, specializing in a broad range of aesthetic and cosmetic products and devices. The company caters to Dermatologists, Plastic Surgeons, Aesthetic Physicians, and Cosmetologists by offering a variety of specialized products. Its portfolio includes both in-house developed items and internationally sourced devices from countries such as South Korea, Spain, Italy, and Austria. These products and devices are supplied to medical professionals who either use them in treatments or offer them to clients.

Aakaar’s product lineup features Homecare and Professional Skincare, Injectable and Contouring solutions, Hair Growth Serums and Tablets, Medifacial Kits, and specialized devices for urinary incontinence, tattoo removal, pigmentation treatment, skin rejuvenation, laser hair reduction, and hair transplantation. The company currently employs a team of 90 trained engineers and sales professionals. It operates across several key states in India, including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.

Objects of the Issue (JNK India IPO Objectives)

• Funding working capital requirements of the Company
• General corporate purposes

JNK India IPO Review (Apply)

• IPO Watch – May Apply
• Canara Bank
• DRChoksey FinServ
• Emkay Global
• Hem Securities
• IDBI Capital
• Marwadi Shares
• Nirmal Bang
• SBICAP Securities
• Sharekhan
• SMC Global
• Sushil Finance
• Swastika Investmart
• Ventura Securities
• Geojit
• Reliance Securities
• Capital Market
• BP Wealth
• ICICIdirect
• Choice Broking

Aakaar Medical Technologies IPO Company Financial Report

Aakaar Medical Technologies IPO Company Financial Report